Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 86%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,860
Total Claims
$1.1M
Drug Cost
535
Beneficiaries
$2,128
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+135%
Opioid rate vs peers
5.3% vs 2.2% avg
+51%
Cost per patient vs peers
$2,128 vs $1,411 avg
+2%
Brand preference vs peers
10.9% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.3%
Opioid Rate
676
Opioid Claims
$11K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,385 claims · $821K
Generic: 11,371 claims · $311K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 159 | $130K |
| Dulaglutide | 45 | $52K |
| Sitagliptin Phosphate | 42 | $44K |
| Rivaroxaban | 38 | $43K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $38K |
| Fluticasone/Umeclidin/Vilanter | 48 | $34K |
| Insulin Lispro | 40 | $31K |
| Tirzepatide | 28 | $31K |
| Dapagliflozin Propanediol | 36 | $31K |
| Empagliflozin | 35 | $30K |
| Sacubitril/Valsartan | 33 | $27K |
| Evolocumab | 39 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 12 | $21K |
| Insulin Aspart | 22 | $19K |
| Semaglutide | 18 | $18K |
Prescribing Profile
Patient Profile
74
Avg Age
56%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About